Physician profile
Brandy M Counts
NPI 1336779826
$411.52
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.93 · 2022: $135 · 2023: $180 · 2024: $17.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.12 | 2021-2024 | Jardiance, Ofev |
| Astrazeneca Pharmaceuticals Lp | $80.24 | 2021-2023 | Breztri, Fasenra |
| Merck Sharp & Dohme LLC | $77.85 | 2021-2023 | Zerbaxa, Dificid, Recarbrio |
| Glaxosmithkline, LLC. | $45.53 | 2022-2023 | Nucala, Trelegy Ellipta |
| Baxter Healthcare | $32.58 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Biohaven Pharmaceutical Holding Company Ltd. | $25.86 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.99 | 2022 | |
| Mylan Specialty L.P. | $19.10 | 2023 | Yupelri |
| Arbor Pharmaceuticals, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Counts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.